Panel Discussion: Pursuing the Next Gold Standard in Biomarker Development: Interrogating the Roadmap from Experimental to Validated
Time: 11:30 am
day: Track 2 - Day 1 AM
• Developing molecular multi-marker panels to investigate how novel therapeutics interfere with disease processes and validating with longitudinal data
• Proteomics, urinary transcriptomics, PROs and microRNA analysis: what correlates with clinical outcome and what is needed for validation?
• How aggressively can we pursue surrogate endpoints?